You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4

Citation Tools

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS11. Ovarian cancer
TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Duska L, Richardson D, Jada SR, et al
TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4
International Journal of Gynecologic Cancer 2023;33:A251.